STOCK TITAN

Uipath Inc Stock Price, News & Analysis

PATH NYSE

Welcome to our dedicated page for Uipath news (Ticker: PATH), a resource for investors and traders seeking the latest updates and insights on Uipath stock.

Stay informed about UiPath Inc. (PATH), the leader in enterprise robotic process automation, through our comprehensive news repository. This page aggregates official press releases, financial disclosures, and market analysis related to UiPath's automation solutions that combine AI, machine learning, and API integrations.

Investors and industry professionals will find timely updates on quarterly earnings, product innovations, and strategic partnerships. Our curated collection includes details on UiPath's expanding automation ecosystem, integration capabilities with major business platforms, and evolving applications across finance, healthcare, and technology sectors.

All content undergoes strict verification to ensure accuracy and relevance. Bookmark this page for real-time updates on UiPath's market position, regulatory filings, and leadership developments within the competitive RPA landscape. Check regularly for insights into how the company's automation technologies continue reshaping global business processes.

Rhea-AI Summary

UiPath has been recognized as a Leader in The Forrester Wave™: Robotic Process Automation, Q1 2023, achieving top scores in Current Offering, Strategy, and Market Presence among 15 evaluated vendors. The analysis highlighted UiPath as the largest RPA vendor by revenue, evolving into a business automation platform with capabilities such as process mining and low-code app development. The report also praised its superior governance features and effective SaaS deployments. The recognition confirms UiPath's commitment to innovation and enhancing productivity for businesses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
none
-
Rhea-AI Summary

UiPath (NYSE: PATH) announced that Mitsubishi Tanabe Pharma has implemented its Business Automation Platform to enhance operational efficiency. Since 2019, over 500 workflows have been automated, saving 70,000 hours and significantly improving productivity. The automation has modernized tasks such as retiree communication and R&D information gathering. The collaboration promotes a no-code/low-code development approach, empowering employees to automate tasks. UiPath aims to support Mitsubishi Tanabe Pharma's digital transformation and workforce enhancement, fostering a hybrid human-digital workforce.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
Rhea-AI Summary

UiPath, Inc. (NYSE: PATH) will disclose its fiscal fourth quarter and full year 2023 financial results on March 15, 2023, after market close. The conference call, scheduled for 5:00 pm ET, will be hosted by management to discuss these results. Investors can access a live call at 1-877-407-8309 (US/Canada) or 1-201-689-8057 (Toll). A replay and webcast will be available on UiPath's investor relations website for one year. The company's vision is to create the Fully Automated Enterprise™, leveraging their leading RPA solutions to enhance digital operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.63%
Tags
-
Rhea-AI Summary

UiPath (NYSE: PATH) has been awarded the 2022 NorthFace ScoreBoard Service Award℠ for the third consecutive year, recognizing its excellence in customer service and support. The award is given by the Customer Relationship Management Institute (CRMI) based on customer satisfaction ratings. UiPath achieved a Customer Satisfaction (CSAT) rating of 94% in 2022, an increase from 91% in 2021, significantly surpassing the software industry average CSAT of 77%. This recognition underscores UiPath's commitment to customer-centricity and strengthening long-term customer loyalty.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
-
Rhea-AI Summary

UiPath (NYSE: PATH) has partnered with the Romanian Red Cross to enhance its reporting capabilities for donations aiding Ukrainian refugees. This initiative was vital due to the increased reporting demands stemming from the ongoing humanitarian crisis in Ukraine. By implementing the UiPath Business Automation Platform, the RRC automated data collection, improving accuracy and reducing reporting time from 8-12 hours to just 30 minutes.

This partnership also facilitated better decision-making and transparency, thus enhancing fundraising efforts. The project showcases how automation can empower organizations facing humanitarian challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.42%
Tags
none
Rhea-AI Summary

UiPath (NYSE: PATH) has announced significant upgrades to its Test Suite, enhancing automated testing capabilities for customers. This update allows organizations to migrate testing to the UiPath Business Automation Platform, reducing costs by consolidating legacy testing solutions. Key features include a migration accelerator service for easy transfer of testing assets and the Test Manager Hub, which integrates with over 40 popular Application Lifecycle Management (ALM) tools. Dr. Gerd Weishaar, VP of Product Management, emphasized that these upgrades enable quicker and cost-effective software testing outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.98%
Tags
none
-
Rhea-AI Summary

UiPath, a leading enterprise automation software company, will have Co-CEO Rob Enslin present at the 25th Annual Needham Growth Conference on January 11th at 3:00 pm ET. The event will take place at Lotte New York Palace and will feature a live audio webcast accessible through the company's Investor Relations webpage. UiPath aims to deliver the Fully Automated Enterprise, providing an end-to-end automation platform that enhances digital business operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.59%
Tags
conferences
-
Rhea-AI Summary

UiPath, Inc. (NYSE: PATH) reported third-quarter fiscal 2023 results with a 36% year-over-year growth in Annual Recurring Revenue (ARR), reaching $1.110 billion, and net new ARR of $67 million. Revenue increased 19% year-over-year to $262.7 million. The company achieved a 126% dollar-based net retention rate, but reported a GAAP operating loss of $(67 million). For Q4 2023, UiPath anticipates revenue between $277 million and $279 million and ARR of $1,174 million to $1,176 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.46%
Tags
Rhea-AI Summary

UiPath (NYSE:PATH) partners with Orica (ASX: ORI) to enhance application testing and automation capabilities. This partnership positions UiPath as Orica's preferred technology partner for enterprise automation. Orica will utilize the UiPath Test Suite to improve its software testing processes, ensuring quality assurance without disrupting workflows. The initiative aims to migrate Orica's enterprise automation program to the UiPath platform by March 2023, driving efficiencies and minimizing costs associated with testing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.61%
Tags
partnership

FAQ

What is the current stock price of Uipath (PATH)?

The current stock price of Uipath (PATH) is $13.21 as of June 6, 2025.

What is the market cap of Uipath (PATH)?

The market cap of Uipath (PATH) is approximately 6.9B.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Stock Data

6.92B
418.07M
7.02%
67.81%
6.11%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK